[HTML][HTML] Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia
TP Hughes, J Kaeda, S Branford… - … England Journal of …, 2003 - Mass Medical Soc
Background In a randomized trial, 1106 patients with chronic myeloid leukemia (CML) in
chronic phase were assigned to imatinib or interferon alfa plus cytarabine as initial therapy …
chronic phase were assigned to imatinib or interferon alfa plus cytarabine as initial therapy …
[PDF][PDF] Frequency of Major Molecular Responses to Imatinib or Interferon Alfa plus Cytarabine in Newly Diagnosed Chronic Myeloid Leukemia
TP Hughes, J Kaeda, S Branford, Z Rudzki… - N Engl J …, 2003 - researchgate.net
In a randomized trial, 1106 patients with chronic myeloid leukemia (CML) in chronic phase
were assigned to imatinib or interferon alfa plus cytarabine as initial therapy. We measured …
were assigned to imatinib or interferon alfa plus cytarabine as initial therapy. We measured …
Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia
TP Hughes, J Kaeda, S Branford… - … England Journal of …, 2003 - research.sahmri.org.au
BACKGROUND: In a randomized trial, 1106 patients with chronic myeloid leukemia (CML)
in chronic phase were assigned to imatinib or interferon alfa plus cytarabine as initial …
in chronic phase were assigned to imatinib or interferon alfa plus cytarabine as initial …
Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia
TP Hughes, J Kaeda, S Branford… - The New England …, 2003 - pubmed.ncbi.nlm.nih.gov
Background In a randomized trial, 1106 patients with chronic myeloid leukemia (CML) in
chronic phase were assigned to imatinib or interferon alfa plus cytarabine as initial therapy …
chronic phase were assigned to imatinib or interferon alfa plus cytarabine as initial therapy …
Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia.
TP Hughes, J Kaeda, S Branford, Z Rudzki… - The New England …, 2003 - europepmc.org
Background In a randomized trial, 1106 patients with chronic myeloid leukemia (CML) in
chronic phase were assigned to imatinib or interferon alfa plus cytarabine as initial therapy …
chronic phase were assigned to imatinib or interferon alfa plus cytarabine as initial therapy …
[引用][C] Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia
TP HUGHES, J KAEDA, JP RADICH… - The New England …, 2003 - pascal-francis.inist.fr
Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in
newly diagnosed chronic myeloid leukemia CNRS Inist Pascal-Francis CNRS Pascal and …
newly diagnosed chronic myeloid leukemia CNRS Inist Pascal-Francis CNRS Pascal and …
Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia
T Hughes, J Kaeda, S Branford, Z Rudzki… - 2003 - hekyll.services.adelaide.edu.au
Background In a randomized trial, 1106 patients with chronic myeloid leukemia (CML) in
chronic phase were assigned to imatinib or interferon alfa plus cytarabine as initial therapy …
chronic phase were assigned to imatinib or interferon alfa plus cytarabine as initial therapy …
Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia
TP Hughes, J Kaeda, S Branford, Z Rudzki - New England Journal of …, 2003 - elibrary.ru
One year after the start of treatment, 137 of 240 patients in the imatinib group who had a
complete cytogenetic remission (57 percent) had a reduction in the levels of BCR-ABL …
complete cytogenetic remission (57 percent) had a reduction in the levels of BCR-ABL …
Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia
T Hughes, J Kaeda, S Branford, Z Rudzki… - 2003 - digital.library.adelaide.edu.au
Background In a randomized trial, 1106 patients with chronic myeloid leukemia (CML) in
chronic phase were assigned to imatinib or interferon alfa plus cytarabine as initial therapy …
chronic phase were assigned to imatinib or interferon alfa plus cytarabine as initial therapy …
[引用][C] Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia
H TP - N Engl J Med., 2003 - cir.nii.ac.jp
Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly
diagnosed chronic myeloid leukemia | CiNii Research CiNii 国立情報学研究所 学術情報 …
diagnosed chronic myeloid leukemia | CiNii Research CiNii 国立情報学研究所 学術情報 …